1. Home
  2. VZLA vs NTLA Comparison

VZLA vs NTLA Comparison

Compare VZLA & NTLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VZLA
  • NTLA
  • Stock Information
  • Founded
  • VZLA 2017
  • NTLA 2014
  • Country
  • VZLA Canada
  • NTLA United States
  • Employees
  • VZLA N/A
  • NTLA N/A
  • Industry
  • VZLA
  • NTLA Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • VZLA
  • NTLA Health Care
  • Exchange
  • VZLA Nasdaq
  • NTLA Nasdaq
  • Market Cap
  • VZLA 649.3M
  • NTLA 710.1M
  • IPO Year
  • VZLA N/A
  • NTLA 2016
  • Fundamental
  • Price
  • VZLA $3.09
  • NTLA $7.16
  • Analyst Decision
  • VZLA Strong Buy
  • NTLA Buy
  • Analyst Count
  • VZLA 3
  • NTLA 20
  • Target Price
  • VZLA $3.83
  • NTLA $38.40
  • AVG Volume (30 Days)
  • VZLA 3.6M
  • NTLA 5.1M
  • Earning Date
  • VZLA 07-18-2025
  • NTLA 05-08-2025
  • Dividend Yield
  • VZLA N/A
  • NTLA N/A
  • EPS Growth
  • VZLA N/A
  • NTLA N/A
  • EPS
  • VZLA N/A
  • NTLA N/A
  • Revenue
  • VZLA N/A
  • NTLA $45,569,000.00
  • Revenue This Year
  • VZLA N/A
  • NTLA N/A
  • Revenue Next Year
  • VZLA N/A
  • NTLA N/A
  • P/E Ratio
  • VZLA N/A
  • NTLA N/A
  • Revenue Growth
  • VZLA N/A
  • NTLA N/A
  • 52 Week Low
  • VZLA $1.67
  • NTLA $5.90
  • 52 Week High
  • VZLA $3.12
  • NTLA $28.18
  • Technical
  • Relative Strength Index (RSI)
  • VZLA 75.11
  • NTLA 40.89
  • Support Level
  • VZLA $2.77
  • NTLA $6.83
  • Resistance Level
  • VZLA $2.97
  • NTLA $9.79
  • Average True Range (ATR)
  • VZLA 0.14
  • NTLA 0.60
  • MACD
  • VZLA 0.05
  • NTLA -0.21
  • Stochastic Oscillator
  • VZLA 97.14
  • NTLA 11.17

About VZLA Vizsla Silver Corp.

Vizsla Silver Corp is a junior mineral exploration and development company focused on advancing its Panuco silver-gold project located in Sinaloa, Mexico. The property contains quartz-carbonate veins with workings defining both steeply plunging and sub-horizontal ore shoots. Mineralization occurs as silver sulphides including argentite and acanthite, native gold, electrum and native silver associated with pyrite, minor galena, sphalerite and rare chalcopyrite. It has one operating segment, which is principally mineral exploration.

About NTLA Intellia Therapeutics Inc.

Intellia Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. Intellia is focused on using this technology to treat genetically defined diseases. It's evaluating multiple gene editing approaches using in vivo and ex vivo therapies to address diseases with high unmet medical needs, including ATTR amyloidosis, hereditary angioedema, sickle cell disease, and immuno-oncology. Intellia has formed collaborations with several companies to advance its pipeline, including narrow-moat Regeneron and wide-moat Novartis.

Share on Social Networks: